Abstract
An hallucinogenic drug is defined in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) as, "any agent which has alterations in perception, cognition and mood as its primary psychobiological actions in the presence of a clear sensorium".
| Original language | English |
|---|---|
| Title of host publication | xPharm: The Comprehensive Pharmacology Reference |
| Publisher | Elsevier Inc. |
| Pages | 1-7 |
| Number of pages | 7 |
| ISBN (Print) | 9780080552323 |
| DOIs | |
| State | Published - 2011 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)
Cite this
Hallucinogen abuse. / Warsi, Mustafa; Marcil, William; Petty, Fred.
xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2011. p. 1-7.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Hallucinogen abuse
AU - Warsi, Mustafa
AU - Marcil, William
AU - Petty, Fred
PY - 2011
Y1 - 2011
N2 - An hallucinogenic drug is defined in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) as, "any agent which has alterations in perception, cognition and mood as its primary psychobiological actions in the presence of a clear sensorium".
AB - An hallucinogenic drug is defined in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) as, "any agent which has alterations in perception, cognition and mood as its primary psychobiological actions in the presence of a clear sensorium".
UR - http://www.scopus.com/inward/record.url?scp=84884107894&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884107894&partnerID=8YFLogxK
U2 - 10.1016/B978-008055232-3.60669-5
DO - 10.1016/B978-008055232-3.60669-5
M3 - Chapter
SN - 9780080552323
SP - 1
EP - 7
BT - xPharm: The Comprehensive Pharmacology Reference
PB - Elsevier Inc.
ER -